Structure Therapeutics Statistics
NASDAQ: GPCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
26.68-0.79 (-2.88%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 26.68 0.00%
Structure Therapeutics by the numbers
Structure Therapeutics has a market capitalization of $1.90 billion based on 71.31M shares outstanding. With trailing EPS of $-3.03, Structure Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 39.2% below its 50-day average and 49.8% below its 200-day average.
Average daily trading volume is 954.53K shares, or about $25.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GPCR valuation vs. peer median
| Metric | GPCR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.90B | $1.96B | -3% |
| Avg. volume | 954.53K | 928.79K | +3% |
Peer median across 8 companies: LKFT, MLYS, URGN, PRGO, ZYME, AGIO, PVLA, SDGR.
Valuation
- Market cap
- $1.90B
- EPS (TTM)
- $-3.03
- Shares outstanding
- 71.31M
Price and trading
- Previous close
- 27.47
- Open
- 27.14
- Day range
- 26.38 – 28.05
- 52-week range
- 25.59 – 94.90
- 52-week change
- -6.12%
- Beta
- —
- Volume
- 1.05M
- Average volume
- 954.53K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.90B
- Forward Pe
- -12.63
- Eps
- -3.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 94.90
- Week52 Low
- 25.59
- Avg Volume
- 954.53K
- Shares Outstanding
- 71.31M
- Ma50
- 43.85
- Ma200
- 53.19
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -71.89%
- Pct From52w Low
- 4.26%